SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

AFJK is experiencing extreme volatility and multiple trading halts, driven by speculation of a business combination and comparisons to previous high-flying stocks like SPRB and SMX. The community is actively discussing potential price targets, halt patterns, and whether this run has similarities to other recent meme stock surges, while some traders caution about the risks associated with chasing halted stocks.

Lion Group Holding Ltd. operates an all-in-one, state-of-the-art trading platform that offers a wide spectrum of products and services. It operates through the following segments: Futures and Securities Brokerage Services, Contract-For-Difference (CFD) Trading, Total Return Service (TRS) Trading and OTC Stock Option Trading. The company was founded by Jian Wang in 2015 and is headquartered in Singapore.

Lion Group Holding Ltd - ADR

Lion Group Holding Ltd

LGHL is trending due to speculation of a potential short squeeze and comparisons to other recently volatile low-float stocks. Community members are discussing its small float, high short interest, and potential for significant price movement, drawing parallels to the runs of $SMX and $AFJK. Some investors also point to the company's Bitcoin holdings as a potential catalyst.

Oriental Culture Holding Ltd. operates as a holding company, which is engaged in providing collectibles and artwork e-commerce services through its subsidiaries. The firm facilitates trading by individual customers of all kinds of collectibles, artwork, and certain commodities on its online platform owned by its subsidiary in Hong Kong, namely the China International Assets and Equity of Artworks Exchange Limited. It provides services including investor education, market information, customer support, and technology infrastructure. The company was founded in March 2018 and is headquartered in Hong Kong.

Oriental Culture Holding Ltd

OCG is trending due to high volatility and speculation around a potential short squeeze, with community members actively discussing price targets and possible catalysts. The stock's low float and history of significant price swings are contributing to the heightened interest. Some traders are also drawing comparisons to other Chinese stocks that have experienced similar momentum.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid discussions of higher-than-expected expenses for 2026, driven by growth investments and compensation costs, leading to community debate about the bank's future profitability.  Concerns are circulating regarding potential economic impacts and comparisons to past financial crises, while some investors express confidence in JPM's strong position and AI investments. There is also discussion around JPMorgan's role in the crypto space, particularly concerning Bitcoin and Microstrategy.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is trending amidst a surge to new highs, sparking debate about whether it's a genuine breakout fueled by industrial demand, a physical squeeze, or simply overbought conditions. Community members highlight silver's increasing use in technology and green energy, along with potential impacts from monetary policy and supply constraints, while others caution about overvaluation and potential pullbacks. Traders are actively discussing entry and exit strategies amid volatility and bullish sentiment.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin, $CAW, is gaining traction as a multichain asset with a burning mechanism, attracting a strong community. Bullish sentiment is fueled by its presence on multiple chains like $SOL, $ETH, and $CRO, with community members emphasizing its organic growth.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending as investors discuss its valuation, particularly highlighting a recent analyst price target of $60 based on the company's digital asset segment and data center business. Community members are pointing to the company's alignment with cryptocurrency regulations and anticipating significant moves related to data center revenue, with some suggesting a potential overdue bounce.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending due to a recent share offering, sparking concerns about dilution and management's communication. While some investors view the offering as a strategic move for future growth, others express disappointment and a loss of confidence. Community discussions revolve around the potential impact of the offering, upcoming Fed decisions, and the stock's exclusion from the S&P 500.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to a JP Morgan upgrade, including a price target significantly higher than the current trading price, sparking community discussion of a potential squeeze. Community members are actively discussing the possibility of further upward movement and short positions. The stock is also discussed in the context of the broader biotech sector and potential clinical catalysts.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending ahead of earnings, with the community keenly anticipating the results and discussing potential catalysts like a share buyback or positive EPS. Investors are also speculating on Ryan Cohen's plans for the company's cash reserves and possible announcements, referencing his recent cryptic ice cream tweet. Some traders are bracing for market maker games and volatility post-earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AUTL Cabaletta is not &quot;chemo-free&quot; at all, it&#39;s similar to Aucatzyl. Kelonia reports on the first three patients treated with anti-BCMA product. It&#39;s many years away from anything competing with Aucatzyl.

$AUTL ASH  
 
Kelonia Therapeutics (Tuesday Presenter): The &quot;Tuesday Risk&quot; for Autolus is likely Kelonia, who is scheduled to present in the 7:30 - 9:00 AM session. 
 
The Threat: Kelonia is presenting data on KLN-1010, their in vivo CAR-T. 
 
The Connection: Like Cabaletta’s &quot;Chemo-Free&quot; hope, Kelonia’s goal is to remove the heavy chemo/hospitalization burden entirely by using an injectable gene therapy. 
 
If Kelonia shows safety/efficacy: It hurts Autolus (implies the future is &quot;factory-free&quot;). 
 
If Kelonia shows toxicity (liver issues): It helps Autolus (confirms the &quot;safe&quot; factory approach is still King). 
 
Cabaletta Bio: While they may not be presenting live Tuesday, their stock will likely move in sympathy with Kelonia&#39;s data. If the &quot;In Vivo / Low Chemo&quot; narrative gets hot on Tuesday morning, CABA stock often rises with it.

StockTwits Web

Autolus Therapeutics Ltd - ADR

Lily Likes her potato

StockTwits For Android 

 Cabaletta is not "chemo-free" at all, it's similar to Aucatzyl. Kelonia reports on the first three patients treated with anti-BCMA product. It's many years away from anything competing with Aucatzyl.

@dgbio The company is actively researching a &quot;chemo-free&quot; (no preconditioning) version of the treatment. As of late 2025, they have presented early data suggesting it might work without chemotherapy, but this is still in the trial phase and not guaranteed for every patient. 
 
Yes Kelonia is years away, but could effect AUTL&#39;s stock price if their data supports a better treatment.  That&#39;s why I wanted to put in that note.   
 
Thanks for your clarification!

 The company is actively researching a "chemo-free" (no preconditioning) version of the treatment. As of late 2025, they have presented early data suggesting it might work without chemotherapy, but this is still in the trial phase and not guaranteed for every patient. 
 
Yes Kelonia is years away, but could effect AUTL's stock price if their data supports a better treatment.  That's why I wanted to put in that note.   
 
Thanks for your clarification!

@Michael_garic Their main approach remains chemo-based